|
Cadila launches Mycidac-C for treatment of lung cancer
NetIndian “Mycidac-C is an innovative research product for the patients suffering from Non Small Cell Lung Cancer (NSCLC). The drug has been approved for launch in India by the Drug Controller General of India (DCGI). It targets Desmocolin-3, a novel target … |
Cadila Pharmaceuticals launches lung cancer drug – Economic Times
|
Cadila Pharmaceuticals launches lung cancer drug
Economic Times As per the company’s statement, Mycidac-C is an innovative research product for the patients suffering from Non Small Cell Lung Cancer (NSCLC). The drug has been approved for launch in India by the Drug Controller General of India (DCGI). It targets … |
Cadila unveils lung cancer drug priced at Rs 40000 for 10 shots – Hindu Business Line
|
Cadila unveils lung cancer drug priced at Rs 40000 for 10 shots
Hindu Business Line According to the World Health Organization (WHO), 1.25 million people are diagnosed with lung cancer annually. “This is the first novel product for cancer management from India,” Modi said, adding that “hundreds of crores” have been spent in developing … |
Cadila Pharma launches affordable lung cancer drug – Business Standard (blog)
Business Standard (blog)Cadila Pharma launches affordable lung cancer drugBusiness Standard (blog)Ahmedabad-based Cadila Pharmaceuticals Limited, a privately held pharma company, has launched the Mycidac-C, an affordable, unique and innovative drug for…
Research and Markets: Global Cancer Monoclonal Antibodies Pipeline Analysis – Business Wire (press release)
Research and Markets: Global Cancer Monoclonal Antibodies Pipeline AnalysisBusiness Wire (press release)In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selective…
Making life better for heart failure patients – Blackpool Gazette
Making life better for heart failure patientsBlackpool GazetteThe 12-month project will offer patients treated for heart failure a 10-week programme of activities aimed at giving them the tools and information they need to self-manage their condition. …
Posthumous award for bike crash victim organ donor – Get Surrey
|
Posthumous award for bike crash victim organ donor
Get Surrey … their organs. “These families are an inspiration to all. With around three people dying every day due to the shortage of organs, we hope these families’ pride will encourage many more to follow in their footsteps and agree to become an organ donor … |
Woman files suit in dietary supplement case tied to liver failure – Honolulu Star-Advertiser
Daily MailWoman files suit in dietary supplement case tied to liver failureHonolulu Star-AdvertiserA Hawaii island woman is suing two companies who made and sold a dietary supplement that was pulled from shelves as health officials investigate links to…
Apollo chairman Prathap Reddy wants West Bengal to pass cadaver transplant act – India.Com Health
Hindu Business LineApollo chairman Prathap Reddy wants West Bengal to pass cadaver transplant actIndia.Com HealthHoping to set up a medical college in the state, Apollo Hospitals Group Chairman Prathap C. Reddy on Wednesday said the West Bengal governm…
UK's first gene therapy trial for patients with chronic heart failure begins … – News-Medical.net
Science Codex |
UK’s first gene therapy trial for patients with chronic heart failure begins …
News-Medical.net The UK’s first gene therapy trial for advanced heart failure, CUPID 2, has officially begun at the Golden Jubilee National Hospital (GJNH); with the first candidate recently being administered with a dose of the MYDICAR treatment. The GJNH, home of the … Study: Genes delivered directly to heart stymie heart failureFierceDrugDelivery 31 months of Gene Therapy Benefits Advanced Heart Failure PatientsNext Big Future Long-lasting gene therapy benefits advanced heart failure patientsMedical Xpress |